Alt solunum yolu infeksiyonlarından izole edilen Streptococcus pneumoniae suşlarının serotiplendirilmesi

Kaynakça (15)

1. Ayyıldız A, Kocazeybek B, Arıtürk S: Cerrahi yoğun bakım hastalarından infeksiyon etkeni olarak izole edilen Gram negatif çomaklarda aminoglikozid direnci, ANKEM Derg 2002;16:78
2. Barr WH, Colucci R, Radwanski E et al: Pharmacokinetics of isepamicin, J Chemother 1995;7(Suppl 2):53
3. Chan-Tack KM: Changing antibiotic sensitivity patterns at a university hospital, 1992 through 1999, South Med J 2001;94(6):619-20
4. Covi M, Velluti G: Comparison of the efficacy and safety of isepamicin and amikacin in the treatment of acute lower respiratory tract infections caused by gram negative organisms, J Chemother 1995;7(Suppl 2):137-42
5. Cunha BA: Pseudomonas aeruginosa: Resistance and therapy, Semin Respir Infect 2002;17(3):231-9
6. Erdem B: Pseudomonaslar, “Ustaçelebi Ş (ed): Temel ve Klinik Mikrobiyoloji” kitabında s.551-8, Güneş Kitapevi, Ankara (1995)
7. Estahbanati HK, Kashani PP, Ghanaatpisheh F: Frequency of Pseudomonas aeruginosa serotypes in burn wound infections and their resistance to antibiotics, Burns 2002;28(4):340-8
8. Günseren F, Mamıkoğlu L, Öztürk S et al: Surveillance study of antimicrobial resistance of gram-negative bacteria isolated from intensive care units in eight hospitals in Turkey, J Antimicrobial Chemother 1999;43(3): 373-8
9. Gür D, Tutar İ, Vardar Ünlü G ve ark: İsepamisinin hastane izolatı Gram-negatif bakterilere karşı in vitro etkisi, Hastane İnfeksiyon Derg 2001;5(Ek 1):19-24
10. Igumbor E, Gwanzura L, Chirara M, Obi C, Muza D: Antibiotic sensitivity and plasmid profiles of Pseudomonas aeruginosa, Afr J Med 2000;46 (11):296-300
11. Landman D, Quale JM, Mayorga D et al: Citywide clonal outbreak of multiresistant Acinetobacter baumannii and Pseudomonas aeruginosa in Brooklyn, NY: the preantibiotic era has returned, Arch Intern Med 2002;162(13):1515-20
12. Leal Del Rosal P: The efficacy and safety of isepamicin compared with amikacin in the treatment of intra-abdominal infections, J Chemother 1995;7(Suppl 2):143-8
13. Mendeş H, Geyik MF, Kökoğlu ÖF, Haşoğlu S, Ayaz C: Hastane ve toplum kaynaklı gram negatif çomaklarda aminoglikozid direnci, X.Türk Klinik Mikrobiyoloji ve İnfeksiyon Hastalıkları Kongresi, Program kitabı s.268, Adana (2001)
14. Miller GH, Sabatelli FJ, Hare RS and The Aminoglycoside Resistance Study Group: The most frequent aminoglycoside resistance mechanisms-Changes with time and geographic area. A reflection of aminoglycoside usage patterns? Clin Infect Dis 1997;24(Suppl 1):46-62
15. National Commi